Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry

Journal of Proteome Research

Volumn 15, Issue 4, 2016, Pages 1288-1299

  Luo, Ping ^a   Yu, Haoyong ^b   Zhao, Xinjie ^a   Bao, Yuqian ^b   Hong, Christopher S ^c   Zhang, Pin ^b   Tu, Yinfang ^b   Yin, Peiyuan ^a   Gao, Peng ^a   Wei, Li ^b   Zhuang, Zhengping ^c   Jia, Weiping ^b   Xu, Guowang ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

diabetes; metabolic profiling; metabolomics; Roux en Y gastric bypass; RYGB

Indexed keywords

ACYLCARNITINE; AMINO ACID; BILE ACID; BILIRUBIN; FATTY ACID; HIPPURIC ACID; INDICAN; LIPID; TRYPTOPHAN; BIOLOGICAL MARKER; CARNITINE; HIPPURIC ACID DERIVATIVE;

ADOLESCENT; ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BILE ACID BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; DIABETIC PATIENT; ENERGY METABOLISM; FATTY ACID BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; INSULIN SENSITIVITY; INVESTIGATIVE PROCEDURES; LIPID BLOOD LEVEL; LIPID STORAGE; MALE; MASS SPECTROMETRY; METABOLOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REMISSION; ROUX EN Y GASTRIC BYPASS; STOMACH BYPASS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 2; GASTRIC BYPASS SURGERY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INSULIN RESISTANCE; MIDDLE AGED; OBESITY, MORBID; PROCEDURES; PROGNOSIS; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AMINO ACIDS; BILE ACIDS AND SALTS; BILIRUBIN; BIOMARKERS; CARNITINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FATTY ACIDS, NONESTERIFIED; FEMALE; GASTRIC BYPASS; HIPPURATES; HUMANS; INDICAN; INSULIN RESISTANCE; MALE; MASS SPECTROMETRY; METABOLOMICS; MIDDLE AGED; OBESITY, MORBID; OXIDATIVE STRESS; PROGNOSIS; REMISSION INDUCTION; TREATMENT OUTCOME; TRYPTOPHAN; WEIGHT LOSS;

EID: 84963674120     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.6b00022     Document Type: Article

References (58)

1. Ding, D.; Chong, S.; Jalaludin, B.; Comino, E.; Bauman, A. E. Risk factors of incident type 2-diabetes mellitus over a 3-year follow-up: Results from a large Australian sample Diabetes Res. Clin. Pract. 2015, 108, 306-15 10.1016/j.diabres.2015.02.002
2. Lawrence, J. M.; Mayer-Davis, E. J.; Reynolds, K.; Beyer, J.; Pettitt, D. J.; DAgostino, R. B., Jr.; Marcovina, S. M.; Imperatore, G.; Hamman, R. F. Diabetes in Hispanic American youth: prevalence, incidence, demographics, and clinical characteristics: the SEARCH for Diabetes in Youth Study Diabetes Care 2009, 32 (Suppl 2) S123-32 10.2337/dc09-S204
3. Nannipieri, M.; Baldi, S.; Mari, A.; Colligiani, D.; Guarino, D.; Camastra, S.; Barsotti, E.; Berta, R.; Moriconi, D.; Bellini, R.; Anselmino, M.; Ferrannini, E. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones J. Clin. Endocrinol. Metab. 2013, 98, 4391-9 10.1210/jc.2013-2538
4. Chikunguwo, S. M.; Wolfe, L. G.; Dodson, P.; Meador, J. G.; Baugh, N.; Clore, J. N.; Kellum, J. M.; Maher, J. W. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass Surg. Obes. Relat. Dis. 2010, 6, 254-259 10.1016/j.soard.2009.11.003
5. Dixon, J. B.; Chuang, L. M.; Chong, K.; Chen, S. C.; Lambert, G. W.; Straznicky, N. E.; Lambert, E. A.; Lee, W. J. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes Diabetes Care 2013, 36, 20-6 10.2337/dc12-0779
6. Bult, M. J.; van Dalen, T.; Muller, A. F. Surgical treatment of obesity Eur. J. Endocrinol. 2008, 158, 135-45 10.1530/EJE-07-0145
7. Kalarchian, M. A.; Marcus, M. D.; Courcoulas, A. P.; Cheng, Y.; Levine, M. D. Self-report of gastrointestinal side effects after banatne surgery Surg. Obes. Relat. Dis. 2014, 10, 1202-1207 10.1016/j.soard.2014.08.007
8. Nicholson, J. K.; Lindon, J. C.; Holmes, E. Metabonomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 1999, 29, 1181-1189 10.1080/004982599238047
9. Gu, Y.; Zhao, A.; Huang, F.; Zhang, Y.; Liu, J.; Wang, C.; Jia, W.; Xie, G.; Jia, W. Very low carbohydrate diet significantly alters the serum metabolic profiles in obese subjects J. Proteome Res. 2013, 12, 5801-11 10.1021/pr4008199
10. Ye, G.; Liu, Y.; Yin, P.; Zeng, Z.; Huang, Q.; Kong, H.; Lu, X.; Zhong, L.; Zhang, Z.; Xu, G. Study of induction chemotherapy efficacy in oral squamous cell carcinoma using pseudotargeted metabolomics J. Proteome Res. 2014, 13, 1994-2004 10.1021/pr4011298
11. Lips, M. A.; Van Klinken, J. B.; van Harmelen, V.; Dharuri, H. K.; t Hoen, P. A. C.; Laros, J. F.; van Ommen, G. J.; Janssen, I. M.; Van Ramshorst, B.; Van Wagensveld, B. A.; Swank, D. J.; Van Dielen, F.; Dane, A.; Harms, A.; Vreeken, R.; Hankemeier, T.; Smit, J. W.; Pijl, H.; Willems van Dijk, K. Roux-en-Y Gastric Bypass Surgery, but Not Calorie Restriction, Reduces Plasma Branched-Chain Amino Acids in Obese Women Independent of Weight Loss or the Presence of Type 2 Diabetes Mellitus Diabetes Care 2014, 37, 3150-3156 10.2337/dc14-0195
12. Mutch, D. M.; Fuhrmann, J. C.; Rein, D.; Wiemer, J. C.; Bouillot, J. L.; Poitou, C.; Clement, K. Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgery PLoS One 2009, 4, e7905 10.1371/journal.pone.0007905
13. Simonen, M.; Dali-Youcef, N.; Kaminska, D.; Venesmaa, S.; Kakela, P.; Paakkonen, M.; Hallikainen, M.; Kolehmainen, M.; Uusitupa, M.; Moilanen, L.; Laakso, M.; Gylling, H.; Patti, M. E.; Auwerx, J.; Pihlajamaki, J. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass Obes. Surg. 2012, 22, 1473-80 10.1007/s11695-012-0673-5
14. Li, J. V.; Ashrafian, H.; Bueter, M.; Kinross, J.; Sands, C.; le Roux, C. W.; Bloom, S. R.; Darzi, A.; Athanasiou, T.; Marchesi, J. R.; Nicholson, J. K.; Holmes, E. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk Gut 2011, 60, 1214-23 10.1136/gut.2010.234708
15. Ashrafian, H.; Li, J. V.; Spagou, K.; Harling, L.; Masson, P.; Darzi, A.; Nicholson, J. K.; Holmes, E.; Athanasiou, T. Bariatric surgery modulates circulating and cardiac metabolites J. Proteome Res. 2014, 13, 570-80 10.1021/pr400748f
16. Li, J. V.; Reshat, R.; Wu, Q.; Ashrafian, H.; Bueter, M.; le Roux, C. W.; Darzi, A.; Athanasiou, T.; Marchesi, J. R.; Nicholson, J. K.; Holmes, E.; Gooderham, N. J. Experimental bariatric surgery in rats generates a cytotoxic chemical environment in the gut contents Front. Microbiol. 2011, 2, 183 10.3389/fmicb.2011.00183
17. Wu, Q.; Li, J. V.; Seyfried, F.; le Roux, C. W.; Ashrafian, H.; Athanasiou, T.; Fenske, W.; Darzi, A.; Nicholson, J. K.; Holmes, E.; Gooderham, N. J. Metabolic phenotype-microRNA data fusion analysis of the systemic consequences of Roux-en-Y gastric bypass surgery Int. J. Obes. 2015, 39, 1126-34 10.1038/ijo.2015.33
18. Yu, H.; Di, J.; Bao, Y.; Zhang, P.; Zhang, L.; Tu, Y.; Han, X.; Jia, W. Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m2 Surg. Obes. Relat. Dis. 2015, 11, 6-11 10.1016/j.soard.2014.06.019
19. Buse, J. B.; Caprio, S.; Cefalu, W. T.; Ceriello, A.; Del Prato, S.; Inzucchi, S. E.; McLaughlin, S.; Phillips, G. L., 2nd; Robertson, R. P.; Rubino, F.; Kahn, R.; Kirkman, M. S. How do we define cure of diabetes? Diabetes Care 2009, 32, 2133-5 10.2337/dc09-9036
20. Yu, H.; Ni, Y.; Bao, Y.; Zhang, P.; Zhao, A.; Chen, T.; Xie, G.; Tu, Y.; Zhang, L.; Su, M.; Wei, L.; Jia, W.; Jia, W. Chenodeoxycholic acid as a potential prognostic marker for Roux-en-Y Gastric Bypass in Chinese obese patients J. Clin. Endocrinol. Metab. 2015, 100, 4222-30 10.1210/jc.2015-2884
21. Tan, Y.; Yin, P.; Tang, L.; Xing, W.; Huang, Q.; Cao, D.; Zhao, X.; Wang, W.; Lu, X.; Xu, Z.; Wang, H.; Xu, G. Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis Mol. Cell. Proteomics 2012, 11, M111 010694 10.1074/mcp.M111.010694
22. Huang, Q.; Tan, Y.; Yin, P.; Ye, G.; Gao, P.; Lu, X.; Wang, H.; Xu, G. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics Cancer Res. 2013, 73, 4992-5002 10.1158/0008-5472.CAN-13-0308
23. Smilde, A. K.; van der Werf, M. J.; Bijlsma, S.; van der Werff-van-der Vat, B. J. C.; Jellema, R. H. Fusion of mass spectrometry-based metabolomics data Anal. Chem. 2005, 77, 6729-6736 10.1021/ac051080y
24. Zhao, X.; Xu, F.; Qi, B.; Hao, S.; Li, Y.; Li, Y.; Zou, L.; Lu, C.; Xu, G.; Hou, L. Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography-mass spectrometry J. Proteome Res. 2014, 13, 1101-11 10.1021/pr401130w
25. Liu, X.; Zheng, P.; Zhao, X.; Zhang, Y.; Hu, C.; Li, J.; Zhao, J.; Zhou, J.; Xie, P.; Xu, G. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry J. Proteome Res. 2015, 14, 2322-30 10.1021/acs.jproteome.5b00144
26. Zhou, L.; Wang, Q.; Yin, P.; Xing, W.; Wu, Z.; Chen, S.; Lu, X.; Zhang, Y.; Lin, X.; Xu, G. Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases Anal. Bioanal. Chem. 2012, 403, 203-13 10.1007/s00216-012-5782-4
27. Zhao, X.; Chen, J.; Ye, L.; Xu, G. Serum metabolomics study of the acute graft rejection in human renal transplantation based on liquid chromatography-mass spectrometry J. Proteome Res. 2014, 13, 2659-67 10.1021/pr5001048
28. Lackey, D. E.; Lynch, C. J.; Olson, K. C.; Mostaedi, R.; Ali, M.; Smith, W. H.; Karpe, F.; Humphreys, S.; Bedinger, D. H.; Dunn, T. N.; Thomas, A. P.; Oort, P. J.; Kieffer, D. A.; Amin, R.; Bettaieb, A.; Haj, F. G.; Permana, P.; Anthony, T. G.; Adams, S. H. Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity Am. J. Physiol. Endocrinol. Metab. 2013, 304, E1175-87 10.1152/ajpendo.00630.2012
29. Herman, M. A.; She, P.; Peroni, O. D.; Lynch, C. J.; Kahn, B. B. Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels J. Biol. Chem. 2010, 285, 11348-56 10.1074/jbc.M109.075184
30. Newgard, C. B. Interplay between lipids and branched-chain amino acids in development of insulin resistance Cell Metab. 2012, 15, 606-14 10.1016/j.cmet.2012.01.024
31. Adams, S. H.; Hoppel, C. L.; Lok, K. H.; Zhao, L.; Wong, S. W.; Minkler, P. E.; Hwang, D. H.; Newman, J. W.; Garvey, W. T. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women J. Nutr. 2009, 139, 1073-81 10.3945/jn.108.103754
32. Befroy, D. E.; Petersen, K. F.; Dufour, S.; Mason, G. F.; de Graaf, R. A.; Rothman, D. L.; Shulman, G. I. Impaired Mitochondrial Substrate Oxidation in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Patients Diabetes 2007, 56, 1376-1381 10.2337/db06-0783
33. Koves, T. R.; Ussher, J. R.; Noland, R. C.; Slentz, D.; Mosedale, M.; Ilkayeva, O.; Bain, J.; Stevens, R.; Dyck, J. R.; Newgard, C. B.; Lopaschuk, G. D.; Muoio, D. M. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance Cell Metab. 2008, 7, 45-56 10.1016/j.cmet.2007.10.013
34. Bonnefont, J. P.; Djouadi, F.; Prip-Buus, C.; Gobin, S.; Munnich, A.; Bastin, J. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects Mol. Aspects Med. 2004, 25, 495-520 10.1016/j.mam.2004.06.004
35. Lodhi, I. J.; Wei, X.; Semenkovich, C. F. Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter Trends Endocrinol. Metab. 2011, 22, 1-8 10.1016/j.tem.2010.09.002
36. Liang, H.; Tantiwong, P.; Sriwijitkamol, A.; Shanmugasundaram, K.; Mohan, S.; Espinoza, S.; Defronzo, R. A.; Dube, J. J.; Musi, N. Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects J. Physiol. 2013, 591, 2897-909 10.1113/jphysiol.2012.247510
37. Roberts, L. D.; Koulman, A.; Griffin, J. L. Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome Lancet Diabetes Endocrinol. 2014, 2, 65-75 10.1016/S2213-8587(13)70143-8
38. Dobrzyn, A.; Ntambi, J. M. Stearoyl-CoA desaturase as a new drug target for obesity treatment Obes. Rev. 2005, 6, 169-74 10.1111/j.1467-789X.2005.00177.x
39. Dobrzyn, A.; Dobrzyn, P.; Lee, S. H.; Miyazaki, M.; Cohen, P.; Asilmaz, E.; Hardie, D. G.; Friedman, J. M.; Ntambi, J. M. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle Am. J. Physiol. Endocrinol. Metab. 2005, 288, E599-607 10.1152/ajpendo.00439.2004
40. Malodobra-Mazur, M.; Dziewulska, A.; Kozinski, K.; Dobrzyn, P.; Kolczynska, K.; Janikiewicz, J.; Dobrzyn, A. Stearoyl-CoA desaturase regulates inflammatory gene expression by changing DNA methylation level in 3T3 adipocytes Int. J. Biochem. Cell Biol. 2014, 55C, 40-50 10.1016/j.biocel.2014.08.005
41. Heemskerk, M. M.; Giera, M.; Bouazzaoui, F. E.; Lips, M. A.; Pijl, H.; van Dijk, K. W.; van Harmelen, V. Increased PUFA Content and 5-Lipoxygenase Pathway Expression Are Associated with Subcutaneous Adipose Tissue Inflammation in Obese Women with Type 2 Diabetes Nutrients 2015, 7, 7676-90 10.3390/nu7095362
42. Mellor, A. L.; Sivakumar, J.; Chandler, P.; Smith, K.; Molina, H.; Mao, D. L.; Munn, D. H. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy Nat. Immunol. 2001, 2, 64-68 10.1038/83183
43. Black, P. H. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II Med. Hypotheses 2006, 67, 879-91 10.1016/j.mehy.2006.04.008
44. Paulmann, N.; Grohmann, M.; Voigt, J. P.; Bert, B.; Vowinckel, J.; Bader, M.; Skelin, M.; Jevsek, M.; Fink, H.; Rupnik, M.; Walther, D. J. Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation PLoS Biol. 2009, 7, e1000229 10.1371/journal.pbio.1000229
45. Graessler, J.; Qin, Y.; Zhong, H.; Zhang, J.; Licinio, J.; Wong, M. L.; Xu, A.; Chavakis, T.; Bornstein, A. B.; Ehrhart-Bornstein, M.; Lamounier-Zepter, V.; Lohmann, T.; Wolf, T.; Bornstein, S. R. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters Pharmacogenomics J. 2013, 13, 514-22 10.1038/tpj.2012.43
46. Roberts, R. E.; Glicksman, C.; Alaghband-Zadeh, J.; Sherwood, R. A.; Akuji, N.; le Roux, C. W. The relationship between postprandial bile acid concentration, GLP-1, PYY and ghrelin Clin. Endocrinol. 2011, 74, 67-72 10.1111/j.1365-2265.2010.03886.x
47. Nicholson, J. K.; Holmes, E.; Wilson, I. D. Gut microorganisms, mammalian metabolism and personalized health care Nat. Rev. Microbiol. 2005, 3, 431-438 10.1038/nrmicro1152
48. Round, J. L.; Mazmanian, S. K. The gut microbiota shapes intestinal immune responses during health and disease Nat. Rev. Immunol. 2009, 9, 313-323 10.1038/nri2515
49. Fiorucci, S.; Mencarelli, A.; Palladino, G.; Cipriani, S. Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders Trends Pharmacol. Sci. 2009, 30, 570-80 10.1016/j.tips.2009.08.001
50. Qiao, L.; Han, S. I.; Fang, Y.; Park, J. S.; Gupta, S.; Gilfor, D.; Amorino, G.; Valerie, K.; Sealy, L.; Engelhardt, J. F.; Grant, S.; Hylemon, P. B.; Dent, P. Bile Acid Regulation of C/EBP, CREB, and c-Jun Function, via the Extracellular Signal-Regulated Kinase and c-Jun NH2-Terminal Kinase Pathways, Modulates the Apoptotic Response of Hepatocytes Mol. Cell. Biol. 2003, 23, 3052-3066 10.1128/MCB.23.9.3052-3066.2003
51. Wang, H.; Chen, J.; Hollister, K.; Sowers, L. C.; Forman, B. M. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR Mol. Cell 1999, 3, 543-553 10.1016/S1097-2765(00)80348-2
52. Ballestri, S.; Zona, S.; Targher, G.; Romagnoli, D.; Baldelli, E.; Nascimbeni, F.; Roverato, A.; Guaraldi, G.; Lonardo, A. Nonalcoholic fatty liver disease is associated with an almost two-fold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis J. Gastroenterol. Hepatol. 2015, n/a 10.1111/jgh.13264
53. Vernon, G.; Baranova, A.; Younossi, Z. M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment. Pharmacol. Ther. 2011, 34, 274-85 10.1111/j.1365-2036.2011.04724.x
54. Stocker, R.; Yamamoto, Y.; McDonagh, A. F.; Glazer, A. N.; Ames, B. N. Bilirubin is an antioxidant of possible physiological importance Science 1987, 235, 1043-1046 10.1126/science.3029864
55. Abbasi, A. Mendelian randomization studies of biomarkers and type 2 diabetes Endocr. Connect. 2015, 4, 249-260 10.1530/EC-15-0087
56. Fu, Y. Y.; Kang, K. J.; Ahn, J. M.; Kim, H.-R.; Na, K. Y.; Chae, D.-W.; Kim, S.; Chin, H. J. Hyperbilirubinemia Reduces the Streptozotocin-Induced Pancreatic Damage through Attenuating the Oxidative Stress in the Gunn Rat Tohoku J. Exp. Med. 2010, 222, 265-273 10.1620/tjem.222.265
57. Dong, H.; Huang, H.; Yun, X.; Kim, D.-s.; Yue, Y.; Wu, H.; Sutter, A.; Chavin, K. D.; Otterbein, L. E.; Adams, D. B.; Kim, Y.-B.; Wang, H. Bilirubin Increases Insulin Sensitivity in Leptin-Receptor Deficient and Diet-Induced Obese Mice Through Suppression of ER Stress and Chronic Inflammation Endocrinology 2014, 155, 818-828 10.1210/en.2013-1667
58. Abbasi, A.; Deetman, P. E.; Corpeleijn, E.; Gansevoort, R. T.; Gans, R. O.; Hillege, H. L.; van der Harst, P.; Stolk, R. P.; Navis, G.; Alizadeh, B. Z.; Bakker, S. J. Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study Diabetes 2015, 64, 1459-69 10.2337/db14-0228